Purchase Order 36C25623P1258
- Not listed
- This $99,497.46 firm fixed-price purchase order was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract is for the delivery of Novocure's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services to VA medical centers. Novocure's proprietary Optune system delivers alternating electric...
- This is a $49,748.73 firm-fixed-price delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract is for the provision of Novocure's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services for the treatment of glioblastoma and mesothelioma at VA medical facilities. The...
- This is a firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract, valued at $49,748.73, is for the provision of Novocure's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services. The contract does not utilize any set-aside designations. Novocure acts...
- This is a firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit medical device manufacturer. The contract, valued at $49,748.73, is for the provision of Novocure's Optune system, which utilizes Tumor Treating Fields (TTFields) technology to treat solid tumor cancers, primarily glioblastoma and mesothelioma. The contract is part of Novocure's Federal Supply Schedule...
- This is a $49,748.73 firm fixed-price federal contract award to Novocure Inc., a foreign-owned, for-profit medical device manufacturer, by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract is for the delivery of Novocure's Optune system, which utilizes Tumor Treating Fields (TTFields) technology to treat solid tumor cancers, primarily glioblastoma and mesothelioma. The award is structured as a purchase order under Novocure's existing 5-year, $28.85...
- This is a firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit medical device manufacturer. The $49,748.73 contract is for the delivery of Novocure's Optune system, a medical device that utilizes Tumor Treating Fields (TTFields) technology to treat solid tumor cancers, primarily glioblastoma and mesothelioma. This contract is part of Novocure's larger $28.85 million Federal...
- This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract, valued at $21,000.00, is for the delivery of Novocure's Optune Plus Transducers, which are part of the company's Optune system for delivering Tumor Treating Fields (TTFields) therapy to treat solid tumor cancers, including glioblastoma and mesothelioma. This contract is not...
- The U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a $49,748.73 firm-fixed-price delivery order contract to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract is for the provision of Novocure's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services to VA medical facilities nationwide. This delivery order is issued under Novocure's existing...
- This is a federal contract award to Novocure Inc., a foreign-owned, for-profit medical device manufacturer, by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract is a $49,748.73 firm fixed-price purchase order for the delivery of Novocure's Optune medical device system, which utilizes Tumor Treating Fields (TTFields) technology to treat solid tumor cancers, primarily glioblastoma and mesothelioma. The contract is not set aside and is issued under...
- This is a firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned for-profit organization, to provide its Optune tumor treating fields (TTFields) therapy devices, transducer arrays, and related equipment rentals and support services for the treatment of solid tumor cancers, including glioblastoma, for veterans at VA medical centers and clinics. The contract has a potential value of $103,914.55 and a...
This is a $49,748.73 firm fixed-price purchase order contract awarded by the Veterans Health Administration (VHA) of the U.S. Department of Veterans Affairs (VA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract is for the provision of Novocure's Optune line of tumor treating fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services. The contract supports the VA's efforts to expand veteran access to innovative cancer treatments, as Novocure's Optune system is FDA-approved for the treatment of glioblastoma and mesothelioma. The contract is not set aside and is part of a larger 5-year Federal Supply Schedule (FSS) contract (ID: 36F79723D0016) awarded to Novocure by the VA VHA in November 2022, with a $28.85 million ceiling value. Delivery orders issued under this FSS contract enable VA medical centers nationwide to efficiently procure Novocure's cancer therapy technologies and services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $49.7k | 7/2/23 |